论文部分内容阅读
目的探讨腹腔镜联合促性腺激素释放激素激动剂治疗子宫内膜异位症的临床效果。方法 94例子宫内膜异位症患者,随机分为实验组和对照组,各47例。实验组给予腹腔镜联合促性腺激素释放激素激动剂进行治疗,对照组单纯给予腹腔镜手术进行治疗,对两组患者术后复发率、疼痛缓解率进行比较和分析。结果与对照组比较,实验组患者复发率及远期疼痛发生率明显较低,性交后疼痛缓解率、痛经及盆腔疼痛缓解率明显较高,差异均具有统计学意义(P<0.05)。结论腹腔镜联合促性腺激素释放激素激动剂治疗子宫内膜异位症效果确切,可有效降低术后复发率,在极大程度上提高了患者术后疼痛缓解率,值得临床推广。
Objective To investigate the clinical effect of laparoscopic combined with gonadotropin-releasing hormone agonist in the treatment of endometriosis. Methods 94 cases of endometriosis patients were randomly divided into experimental group and control group, 47 cases in each. The experimental group was treated with laparoscopic combined with gonadotropin-releasing hormone agonist, while the control group was treated with laparoscopic surgery alone. The recurrence rate and pain relief rate of the two groups were compared and analyzed. Results Compared with the control group, the recurrence rate and the long-term pain rate in the experimental group were significantly lower. The rates of post-intercourse pain relief, dysmenorrhea and pelvic pain relief were significantly higher, with statistical significance (P <0.05). Conclusions Laparoscopic combined with gonadotropin-releasing hormone agonist is effective in treating endometriosis, which can effectively reduce the recurrence rate and greatly improve postoperative pain relief rate, which is worthy of clinical promotion.